Thermomechanical processing of 34CrNiMo6 steel for Large Scale Forging

This work simulated the thermo-mechanical processing of large-scale forging product made of 34CrNiMo6 steel to evaluate the effect of different processing condition parameters and cooling rates on the variation of microstructure and the final mechanical properties. Through this investigation we tried to achieve the required mechanical properties for deep sea applications, which were a minimum Charpy impact value of 38J at temperature of -20 °C according to ABS specifications and a minimum surface hardness of 302 HB according to First Subsea specification design. Initially, a series of single and multi-hit plane strain compression tests were performed to evaluate the hot-deformed microstructure in thermo-mechanical processing, with particular attention paid to the effect of austenitising temperature and deformation conditions of temperature, strain and strain rate. The exponential law, power law and hyperbolic sine law types of Zener–Hollomon equations were utilised to calculate the hot activation energy of deformation (Qdef). In addition the constitutive equations were used for modelling and generalising the DRV and DRX flow curves of 34CrNiMo6 steel, using the method proposed by Avrami. Secondly, a heat treatment process using different austenitising temperatures and different cooling rates was also investigated to achieve the required aims, in which many tests were performed through controlling the temperatures, soaking times, and cooling rates to study the effect of the heat treatment parameters on the grain size and transformation behaviour of austenite. Additionally, to attempt to refine the austenite grain size and to increase the austenite phase percentage within the microstructure, multiple heat treatment paths were also used. A double normalizing, double quenching, and single tempered process were used in all possible combinations to investigate their influence on the final microstructure in an attempt to identify the most effective heat treatment cycle with an effective sequence for the heat treatment operations

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Background Results of small trials indicate that fluoxetine might improve functional outcomes after stroke. The FOCUS trial aimed to provide a precise estimate of these effects. Methods FOCUS was a pragmatic, multicentre, parallel group, double-blind, randomised, placebo-controlled trial done at 103 hospitals in the UK. Patients were eligible if they were aged 18 years or older, had a clinical stroke diagnosis, were enrolled and randomly assigned between 2 days and 15 days after onset, and had focal neurological deficits. Patients were randomly allocated fluoxetine 20 mg or matching placebo orally once daily for 6 months via a web-based system by use of a minimisation algorithm. The primary outcome was functional status, measured with the modified Rankin Scale (mRS), at 6 months. Patients, carers, health-care staff, and the trial team were masked to treatment allocation. Functional status was assessed at 6 months and 12 months after randomisation. Patients were analysed according to their treatment allocation. This trial is registered with the ISRCTN registry, number ISRCTN83290762. Findings Between Sept 10, 2012, and March 31, 2017, 3127 patients were recruited. 1564 patients were allocated fluoxetine and 1563 allocated placebo. mRS data at 6 months were available for 1553 (99·3%) patients in each treatment group. The distribution across mRS categories at 6 months was similar in the fluoxetine and placebo groups (common odds ratio adjusted for minimisation variables 0·951 [95% CI 0·839–1·079]; p=0·439). Patients allocated fluoxetine were less likely than those allocated placebo to develop new depression by 6 months (210 [13·43%] patients vs 269 [17·21%]; difference 3·78% [95% CI 1·26–6·30]; p=0·0033), but they had more bone fractures (45 [2·88%] vs 23 [1·47%]; difference 1·41% [95% CI 0·38–2·43]; p=0·0070). There were no significant differences in any other event at 6 or 12 months. Interpretation Fluoxetine 20 mg given daily for 6 months after acute stroke does not seem to improve functional outcomes. Although the treatment reduced the occurrence of depression, it increased the frequency of bone fractures. These results do not support the routine use of fluoxetine either for the prevention of post-stroke depression or to promote recovery of function. Funding UK Stroke Association and NIHR Health Technology Assessment Programme

Crystal structures of 4-chlorophenyl N-(3,5-dinitrophenyl)carbamate and phenyl N-(3,5-dinitrophenyl)carbamate

The title compounds, C13H8ClN3O6, (I), and C13H9N3O6, (II), differ in the orientation of the two aromatic rings. In (I), they are essentially coplanar, making a dihedral angle of 8.2 (1)°, while in (II), they are inclined to one another by 76.2 (1)°. The two nitro groups are essentially coplanar with the attached benzene rings, as indicated by the dihedral angles of 1.4 (2) and 2.3 (2)° in (I), and 4.96 (18) and 5.4 (2)° in (II). The carbamate group is twisted slightly from the attached benzene ring, with a C—N—C—O torsion angle of −170.17 (15)° for (I) and 168.91 (13)° for (II). In the crystals of of both compounds, molecules are linked via N—H...O hydrogen bonds, forming chains propagating along [010]. In (I), C—H...O hydrogen bonds also link molecules within the chains. The crystal packing in (I) also features a very weak π–π interaction [centroid–centroid distance = 3.7519 (9) Å]

Elimination of 50% Iodine and Excellent Performance of Dye-Sensitized Solar Cell Enabled by TEMPO Radical Dendrimer-Iodide Dual Redox Systems

Detrimental effect of counter electrode corrosion, electrolyte leakage problem, and sublimation of iodine ions affect the performance and stability of dye-sensitized solar cells (DSSCs) based on a liquid redox electrolyte system. TEMPO/TEMPO+ is the most desirable one to replace the existing redox couples in liquid electrolyte owing to its rapid and reversible one electron kinetics, high diffusion coefficient, and electrochemical stability. In the present study, a fifth generation polyurethane dendrimer end-capped with 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) was prepared and employed as an active redox mediator to replace up to 75% of iodine ions in the standard liquid iodide electrolyte system to elucidate the effect of a quick self-exchange reaction in DSSCs. In this concern, quasi-gel type electrolytes were prepared by incorporating different amounts of a newly prepared TEMPO radical dendrimer to a liquid I-/I3- redox system and were used as a dual redox mediator for DSSCs. Blending of 50 wt % of I-/I3- electrolyte with 50 wt % of the radical dendrimer improved the device performance (η) unprecedentedly from 6.56 to 9.54% upon illumination with 1 sun intensity. Thorough electrochemical characterization of cells was carried out and all such parameters authenticated this remarkable enhancement. Stability of the device was also found to be good, which retained its >80% efficiency after 30 days

Free-H2 deoxygenation of Jatropha curcas oil into cleaner diesel-grade biofuel over coconut residue-derived activated carbon catalyst

Diesel-like hydrocarbons were produced by the catalytic deoxygenation (DO) of Jatropha curcas oil (JCO) over novel Agx/AC and Niy-Agx/AC catalysts under an H2-free atmosphere. The AC was synthesized from coconut fibre residues (CFR), where CFR is the by-product from coconut milk extraction and is particularly rich in soft fibres with high mineral content. The Niy-Agx/AC catalyst afforded higher DO activity via the decarboxylation/decarbonylation (deCOx) route than Agx/AC due to the properties of Ni, synergistic interaction of Ni and Ag species, adequate amount of strong acid sites and large number of weak acid sites, which cause extensive C-O cleavage and lead to rich formation of n-(C15+C17) hydrocarbons. The effect of Ag and Ni content were studied within the 5 to 15 wt% range. An optimum Ni and Ag metal content (5 wt%) for deCOx reaction was observed. Excess Ni is not preferable due to a tendency for cracking and Ag-rich containing catalyst weakly enforced triglycerides breaking. The Ni5-Ag5/AC govern exclusively decarbonylation reaction, which corroborates the presence of Ni2+ species and a high amount of strong acid sites. Ultimately, Ni5-Ag5/AC in the present study shows excellent chemical stability with consistent five reusability without drastic reduction of hydrocarbon yield (78–95%) and n-(C15+C17) selectivity (82–83%), which indicate favourable application in JCO DO